tiprankstipranks
Novonesis A/S (UK) (GB:0Q4U)
:0Q4U
UK Market

Novonesis (0Q4U) Financial Statements

Compare
8 Followers

Novonesis Financial Overview

Novonesis's market cap is currently kr185.94B. The company's EPS TTM is kr10.913; its P/E ratio is 36.61; and it has a dividend yield of 1.54%. Novonesis is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is kr3.84. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit-$ 9.58B$ 8.62B$ 7.85B$ 7.95B
Operating Income
EBITDA$ 5.47B$ 6.12B$ 5.40B$ 4.85B$ 5.07B
Net Income
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets
Total Debt$ 0.00$ 411.00M$ 482.00M$ 3.78B$ 2.00B
Net Debt$ 0.00$ -710.00M$ -556.00M$ 2.48B$ 1.27B
Total Liabilities
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Currency in USD

Novonesis Earnings and Revenue History

Novonesis Debt to Assets

Novonesis Cash Flow

Novonesis Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis